FDA issues preliminary guidance for medical devices with Artificial IntelligenceMarketing ELS2025-01-14T17:04:03+00:0014 de January, 2025|
FDA Proposes Draft Guidance to Ensure AI Credibility in Drug and Biologic SubmissionsMarketing ELS2025-01-14T16:21:37+00:0014 de January, 2025|
Progress in Clinical Research in Brazil: New ANVISA RegulationsMarketing ELS2024-12-04T00:27:43+00:004 de December, 2024|
Anvisa publishes panels on Dossier Adequacy Letter for Active Pharmaceutical IngredientsMarketing ELS2024-11-27T00:28:14+00:0027 de November, 2024|
Anvisa updates form for importing Cannabis-derived productsMarketing ELS2024-10-09T19:14:52+01:009 de October, 2024|
Modified the list of medicines with suspended exportsMarketing ELS2024-09-10T16:14:56+01:0010 de September, 2024|
